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Compared with an ‘historic’ reference series including 50 CDIE from 1992 to
1999, no significant microbiology evolution has been demonstrated (p=0.64)
When compared prior to 2000 to following years, the patient’s characteristics
changed. The aging (p=0.01) and the severity of the cardiac disease (p<0.001)
increased but long term mortality remained the same (aOR for 1992-1999
patients long term mortality, 1,061; 95% IC, 0.50 to 2.25; p=0.88).
 
Conclusions:
 
 Microbiology and adjusted mortality of CDIE have not sig-
nificantly changed since the 1990’s. This study shows for the first time a sig-
nificant prognostic difference according to germs involved, with a greater
survival when CNS was incriminated. 
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Introduction: 
 
T wave alternans (TWA) has been demonstrated as a strong
predictor of mortality and ventricular arrhythmias. ICD-stored intracardiac
electrograms (IEGM) present a unique opportunity for detecting temporal rela-
tionship between the occurrence of TWA and spontaneous arrhythmia. The
aim of the ETWAS study was to assess the feasibility of detection of TWA
preceding the onset of VT/VF in IEGM.
 
Methods: 
 
56 implanted patients with St Jude medical ICDs (44 men, 63
± 12 yo, mean EF 34 ± 15 %) were prospectively enrolled and monitored for
one year. Thirteen different T wave parameters were extracted from IEGM
(T amplitude, T peak time, Bazett and Hodges corrected T peak time, T end
time, T duration between baseline crossing and between points of maximal
slopes, T peak to T end, maximal ascending and descending slopes, timing
of points of maximal slopes and T wave area). Successive beat by beat dif-
ferences in each parameter in recordings prior to VT/VF were compared to
control recordings in the same pts. TWA was considered if beat by beat vari-
ations for at least one parameter was significantly higher than baseline with
a p value < 0,01.
 
Results: 
 
22 VT/VF episodes (24 ± 13 beats, 71 ± 17 bpm) and 13 baseline
(25 ± 9 beats, 72 ± 18) (ns) were analyzed in 12 pts (1,8 episode/ pt).
 
 
 
TWA
was present before VT/VF onset in 13 episodes (7 pts) with 1 to 9 differing
parameters (3 ± 2).
 
 
 
Significant beat by beat differences before VT/VF onset
were observed in amplitude, timing, slopes, area and duration of the T wave.
Amplitude of the beat by beat variations was 3 to10 larger in episodes than in
baseline.
Paired and unpaired comparisons of the averaged values of beat by beat
variations however did not reveal significant difference between baseline and
episodes, except for T wave amplitude (0,07 +/– 0,006 vs 0,14 +/– 0,03 mV,
p=0.03 paired and 0,04 unpaired).
 
Conclusions: 
 
Detection of TWA prior to VT/VF might be useful in pre-
dicting imminent arrhythmia occurrence. TWA can be detected before VT/VF
onset in more than half of episodes using a simple time-domain technique and
multiple T wave measurements. T wave amplitude seems the most discrimi-
nant parameter.
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For some authors, positive head-up tilt-test (HUT) and/or ATP-test could
identify patients with vaso-vagal syncope. It has been shown that endoge-
nous adenosine plays a role in the mechanism of syncope in patients with
positive HUT. Indeed, patients with positive HUT have higher adenosine
plasma levels (APL) than patients with negative HUT. Moreover, APL
increase during HUT, only in patients with positive HUT. Adenosine triph-
osphate injection can induce in some patients with unexplained syncope a
cardio-inhibitory but the role of endogenous adenosine in those patients is
unknown.
 
Methods: 
 
In this prospective study we studied APL before and during
ATP-test. Twenty consecutive patients with syncope of unexplained origin
were included (56.0 
 
❑
 
 23.1 y., 13 females). They underwent baseline APL
measurement followed by ATP-test. Then APL was measured 1, 5 and 15
minutes after ATP injection. APL were determined by High Performance
Liquid Chromatography method on venous blood samples obtained in resting
patients. ATP-test consisted of the intravenous bolus injection of 20 mg ATP
during continuous recording of the surface ECG. The test was considered pos-
itive when a ventricular pause of 
 
≥
 
 6 sec. occurred, due either to complete atri-
oventricular block or sinoatrial block.
 
Results: 
 
Nine patients had positive ATP-test. There was no statistical dif-
ference between patients with positive and negative ATP-test at baseline, 1, 5
and 15 minutes after ATP injection: 0.32 
 
❑
 
 0.16 μmol/L
 
 vs 
 
0.49 
 
❑
 
 0.61 μmol/
L, 0.32 
 
❑
 
 0.16 μmol/L
 
 vs 
 
0.37 
 
❑
 
 0.21 μmol/L, 0.29 
 
❑
 
 0.23 μmol/L
 
 vs 
 
0.41 
 
❑
 
0.26 μmol/L, 0.34 
 
❑
 
 0.20 μmol/L
 
 vs 
 
0.28 
 
❑
 
 0.13 μmol/L, respectively. There
was no variation of APL during ATP-test in patients with positive and nega-
tive ATP-test.
 
Conclusion: 
 
Endogenous adenosine is not involved in the mechanism of
ATP-test. These results suggest that ATP-test and HUT have different mecha-
nism and could identify different groups of patients with syncope of unex-
plained origin.
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Objective:
 
 Our aim was to assess single and dual-chamber pacemakers
with a view to updating their reimbursement conditions by French National
Health Insurance.
 
Methods:
 
 We performed a critical appraisal of the clinical literature (2002
– 2008) which was then submitted to a multidisciplinary working group of 10
health professionals for discussion. Manufacturers’ application files were also
consulted.
 
Results:
 
 We analyzed 1 health technology assessment, 1 meta-analysis, 3
guidelines and 3 randomised controlled trials providing data on more than
7000 patients with atrio-ventricular blocks (“AVB”) and/or sick sinus syn-
drome (“SSS”).
Pacing mode did not reduce mortality or heart failure hospitalizations.
Compared with ventricular pacing, atrial-based pacing (physiologic modes)
reduced stroke and atrial fibrillation (“AF”). There was a significant reduc-
tion in the composite outcome of stroke or cardiovascular mortality, but
only among patients with SSS. Results of quality of life, exercise capacity,
functional status and pacemaker syndrome are variable. Physiologic modes
were associated with higher rates of perioperative complications (lead dis-
lodgement and infections). Results were independant of age, sex, hyperten-
